{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:14:30Z","timestamp":1785194070230,"version":"3.55.0"},"reference-count":61,"publisher":"Portland Press Ltd.","issue":"5","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ischemic preconditioning (IPC) is an endogenous protection strategy against myocardial ischemia\u2013reperfusion (I\/R) injury. Macrophage migration inhibitory factor (MIF) released from the myocardium subjected to brief periods of ischemia confers cardioprotection. We hypothesized that MIF plays an essential role in IPC-induced cardioprotection. I\/R was induced either ex vivo or in vivo in male wild-type (WT) and MIF knockout (MIFKO) mice with or without proceeding IPC (three cycles of 5-min ischemia and 5-min reperfusion). Indices of myocardial injury, regional inflammation and cardiac function were determined to evaluate the extent of I\/R injury. Activations of the reperfusion injury salvage kinase (RISK) pathway, AMP-activated protein kinase (AMPK) and their downstream components were investigated to explore the underlying mechanisms. IPC conferred prominent protection in WT hearts evidenced by reduced infarct size (by 33\u201335%), myocyte apoptosis and enzymatic markers of tissue injury, ROS production, inflammatory cell infiltration and MCP1\/CCR2 expression (all P&amp;lt;0.05). IPC also ameliorated cardiac dysfunction both ex vivo and in vivo. These protective effects were abolished in MIFKO hearts. Notably, IPC mediated further activations of RISK pathway, AMPK and the membrane translocation of GLUT4 in WT hearts. Deletion of MIF blunted these changes in response to IPC, which is the likely basis for the absence of protective effects of IPC against I\/R injury. In conclusion, MIF plays a critical role in IPC-mediated cardioprotection under ischemic stress by activating RISK signaling pathway and AMPK. These results provide an insight for developing a novel therapeutic strategy that target MIF to protect ischemic hearts.<\/jats:p>","DOI":"10.1042\/cs20181013","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T17:15:24Z","timestamp":1551114924000},"page":"665-680","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection"],"prefix":"10.1042","volume":"133","author":[{"given":"Amanguli","family":"Ruze","sequence":"first","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Medical Animal Model Research, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Dang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Cardiovascular Research, Urumqi, Xinjiang, China"},{"name":"Clinical Medical Research Institute of Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Cardiovascular Research, Urumqi, Xinjiang, China"},{"name":"Clinical Medical Research Institute of Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Cui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Cardiovascular Research, Urumqi, Xinjiang, China"},{"name":"Clinical Medical Research Institute of Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Tao","family":"Gai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Cardiovascular Research, Urumqi, Xinjiang, China"},{"name":"Clinical Medical Research Institute of Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Cardiovascular Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Tong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Cardiovascular Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Du","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute, and Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-8508","authenticated-orcid":false,"given":"Yi-Ning","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Cardiovascular Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China"},{"name":"Xinjiang Key Laboratory of Cardiovascular Research, Urumqi, Xinjiang, China"},{"name":"Clinical Medical Research Institute of Xinjiang Medical University, Urumqi, China"},{"name":"Baker Heart and Diabetes Institute, and Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"2021113012300561500_B1","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"2021113012300561500_B2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"2021113012300561500_B3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium","volume":"74","author":"Murry","year":"1986","journal-title":"Circulation"},{"key":"2021113012300561500_B4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1161\/01.RES.66.4.1133","article-title":"Ischemic preconditioning reduces infarct size in swine myocardium","volume":"66","author":"Schott","year":"1990","journal-title":"Circ. Res."},{"key":"2021113012300561500_B5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cvr\/26.3.226","article-title":"Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids","volume":"26","author":"Li","year":"1992","journal-title":"Cardiovasc. Res."},{"key":"2021113012300561500_B6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cardiores.2004.04.011","article-title":"Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning","volume":"63","author":"Hausenloy","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"2021113012300561500_B7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00424-007-0321-4","article-title":"Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K\/Akt pathways","volume":"455","author":"Hu","year":"2008","journal-title":"Pflugers. Arch."},{"key":"2021113012300561500_B8","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1371\/journal.pone.0076659","article-title":"Impact of the Phosphatidylinositide 3-Kinase Signaling Pathway on the Cardioprotection Induced by Intermittent Hypoxia","volume":"8","author":"Milano","year":"2013","journal-title":"PLoS One"},{"key":"2021113012300561500_B9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cardiores.2006.01.012","article-title":"Preconditioning, postconditioning and their application to clinical cardiology","volume":"70","author":"Kloner","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"2021113012300561500_B10","doi-asserted-by":"publisher","first-page":"H1723","DOI":"10.1152\/ajpheart.00553.2011","article-title":"Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures","volume":"301","author":"Sanada","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113012300561500_B11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1253\/circj.CJ-12-0132","article-title":"Cardioprotection from ischemia\/reperfusion injury: basic and translational research","volume":"76","author":"Minamino","year":"2012","journal-title":"Circ. J."},{"key":"2021113012300561500_B12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/cvr\/cvp129","article-title":"Protective ischaemia in patients: preconditioning and postconditioning","volume":"83","author":"Granfeldt","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"2021113012300561500_B13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0140-6736(93)91819-8","article-title":"Preconditioning the human myocardium","volume":"342","author":"Yellon","year":"1993","journal-title":"Lancet"},{"key":"2021113012300561500_B14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/eurheartj\/eht346","article-title":"Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial","volume":"35","author":"Hong","year":"2014","journal-title":"Eur. Heart. J."},{"key":"2021113012300561500_B15","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J. Exp. Med."},{"key":"2021113012300561500_B16","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1161\/01.CIR.0000012942.49244.82","article-title":"Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis","volume":"105","author":"Burger-Kentischer","year":"2002","journal-title":"Circulation"},{"key":"2021113012300561500_B17","doi-asserted-by":"publisher","first-page":"H795","DOI":"10.1152\/ajpheart.00189.2004","article-title":"Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury","volume":"288","author":"Willis","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113012300561500_B18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/414920a","article-title":"MIF regulates innate immune responses through modulation of Toll-like receptor 4","volume":"414","author":"Roger","year":"2001","journal-title":"Nature"},{"key":"2021113012300561500_B19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"key":"2021113012300561500_B20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/365756a0","article-title":"MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia","volume":"365","author":"Bernhagen","year":"1993","journal-title":"Nature"},{"key":"2021113012300561500_B21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/sj.gene.6363867","article-title":"A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis","volume":"3","author":"Baugh","year":"2002","journal-title":"Genes. Immun."},{"key":"2021113012300561500_B22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nature06504","article-title":"Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart","volume":"451","author":"Miller","year":"2008","journal-title":"Nature"},{"key":"2021113012300561500_B23","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI39738","article-title":"Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia\/reperfusion","volume":"119","author":"Qi","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2021113012300561500_B24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1089\/ars.2010.3163","article-title":"Macrophage migration inhibitory factor provides cardioprotection during ischemia\/reperfusion by reducing oxidative stress","volume":"14","author":"Koga","year":"2011","journal-title":"Antioxid. Redox. Signal."},{"key":"2021113012300561500_B25","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.111.069104","article-title":"Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor","volume":"125","author":"Luedike","year":"2012","journal-title":"Circulation"},{"key":"2021113012300561500_B26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/CIRCULATIONAHA.112.000862","article-title":"Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction","volume":"128","author":"Wang","year":"2013","journal-title":"Circulation"},{"key":"2021113012300561500_B27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2014.01.015","article-title":"Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction","volume":"69","author":"White","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113012300561500_B28","doi-asserted-by":"publisher","first-page":"e92827","DOI":"10.1371\/journal.pone.0092827","article-title":"The role of macrophage migration inhibitory factor in anesthetic-induced myocardial preconditioning","volume":"9","author":"Goetzenich","year":"2014","journal-title":"PLoS One"},{"key":"2021113012300561500_B29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yjmcc.2013.08.005","article-title":"Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms","volume":"64","author":"Fullmer","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113012300561500_B30","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1097\/CCM.0000000000001350","article-title":"Remifentanil preconditioning reduces postischemic myocardial infarction and improves left ventricular performance via activation of the janus activated kinase-2\/signal transducers and activators of transcription-3 signal pathway and subsequent inhibition of glycogen synthase kinase-3beta in rats","volume":"44","author":"Qiao","year":"2016","journal-title":"Crit. Care Med."},{"key":"2021113012300561500_B31","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1006\/jmcc.1997.0454","article-title":"Ischemic preconditioning and morphine-induced cardioprotection involve the delta (\u03b4)-opioid receptor in the intact rat heart","volume":"29","author":"Schultz","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113012300561500_B32","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1006\/jmcc.2000.1201","article-title":"Expression of active alpha(1B)-adrenergic receptors in the heart does not alleviate ischemic reperfusion injury","volume":"32","author":"Gao","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113012300561500_B33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.yjmcc.2010.12.022","article-title":"Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation","volume":"50","author":"Gao","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113012300561500_B34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.7150\/thno.7729","article-title":"Myocardial protective effect of extracellular superoxide dismutase gene modified bone marrow mesenchymal stromal cells on infarcted mice hearts","volume":"4","author":"Pan","year":"2014","journal-title":"Theranostics"},{"key":"2021113012300561500_B35","doi-asserted-by":"publisher","first-page":"H1068","DOI":"10.1152\/ajpheart.00073.2017","article-title":"Microvascular leakage in acute myocardial infarction: characterization by histology, biochemistry and magnetic resonance imaging","volume":"312","author":"Gao","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113012300561500_B36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tcm.2005.03.001","article-title":"The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning","volume":"15","author":"Hausenloy","year":"2005","journal-title":"Trends. Cardiovasc. Med."},{"key":"2021113012300561500_B37","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1161\/01.CIR.97.18.1848","article-title":"Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop","volume":"97","author":"Kloner","year":"1998","journal-title":"Circulation"},{"key":"2021113012300561500_B38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10557-010-6240-1","article-title":"Postconditioning in reperfusion injury: a status report","volume":"24","author":"Zhao","year":"2010","journal-title":"Cardiovasc. Drugs Ther."},{"key":"2021113012300561500_B39","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/j.1540-8167.2012.02397.x","article-title":"The effect of acute versus delayed remote ischemic preconditioning on reperfusion induced ventricular arrhythmias","volume":"23","author":"Dow","year":"2012","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"2021113012300561500_B40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10557-010-6236-x","article-title":"Mechanism of cardioprotection by early ischemic preconditioning","volume":"24","author":"Yang","year":"2010","journal-title":"Cardiovasc. Drugs Ther."},{"key":"2021113012300561500_B41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/01.CIR.0000151290.04952.3B","article-title":"Postconditioning inhibits mitochondrial permeability transition","volume":"111","author":"Argaud","year":"2005","journal-title":"Circulation"},{"key":"2021113012300561500_B42","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1152\/japplphysiol.00642.2007","article-title":"Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury","volume":"103","author":"Vinten-Johansen","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"2021113012300561500_B43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.110.953208","article-title":"Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart","volume":"122","author":"Ma","year":"2010","journal-title":"Circulation"},{"key":"2021113012300561500_B44","first-page":"138","article-title":"Ischemic preconditioning in the younger and aged heart","volume":"2","author":"Abete","year":"2011","journal-title":"Aging Dis."},{"key":"2021113012300561500_B45","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1253\/jcj.65.984","article-title":"Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-kappaB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart","volume":"65","author":"Hiasa","year":"2001","journal-title":"Jpn. Circ. J."},{"key":"2021113012300561500_B46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10753-016-0462-8","article-title":"Troxerutin preconditioning and ischemic postconditioning modulate inflammatory response after myocardial ischemia\/reperfusion injury in rat model","volume":"40","author":"Badalzadeh","year":"2017","journal-title":"Inflammation"},{"key":"2021113012300561500_B47","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/j.1399-6576.2007.01444.x","article-title":"Pre-treatment with hyperoxia before coronary artery bypass grafting - effects on myocardial injury and inflammatory response","volume":"51","author":"Karu","year":"2007","journal-title":"Acta Anaesthesiol. Scand."},{"key":"2021113012300561500_B48","doi-asserted-by":"publisher","first-page":"e0189501","DOI":"10.1371\/journal.pone.0189501","article-title":"Remote ischemic preconditioning attenuates cardiopulmonary bypass-induced lung injury","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"2021113012300561500_B49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/187152807780832265","article-title":"MCP-1\/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy","volume":"6","author":"Xia","year":"2007","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"2021113012300561500_B50","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pharmthera.2011.12.010","article-title":"Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions","volume":"134","author":"Gao","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"2021113012300561500_B51","doi-asserted-by":"publisher","first-page":"H1723","DOI":"10.1152\/ajpheart.00553.2011","article-title":"Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures","volume":"301","author":"Sanada","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113012300561500_B52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/bja\/aeu302","article-title":"Ischaemic conditioning strategies reduce ischaemia\/reperfusion-induced organ injury","volume":"114","author":"Pac-Soo","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"2021113012300561500_B53","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cardiores.2003.09.031","article-title":"Protein kinase activation and myocardial ischemia\/reperfusion injury","volume":"61","author":"Armstrong","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"2021113012300561500_B54","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1172\/JCI19906","article-title":"Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore","volume":"113","author":"Juhaszova","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2021113012300561500_B55","first-page":"1310","article-title":"Agomelatine protects against myocardial ischemia reperfusion injury by inhibiting mitochondrial permeability transition pore opening","volume":"10","author":"Jia","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"2021113012300561500_B56","doi-asserted-by":"publisher","first-page":"H971","DOI":"10.1152\/ajpheart.00374.2004","article-title":"Ischemic preconditioning protects by activating prosurvival kinases at reperfusion","volume":"288","author":"Hausenloy","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113012300561500_B57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/01.RES.0000012567.95445.55","article-title":"Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase\u2013dependent pathway is cardioprotective","volume":"90","author":"Tong","year":"2002","journal-title":"Circ. Res."},{"key":"2021113012300561500_B58","doi-asserted-by":"publisher","first-page":"e69910","DOI":"10.1371\/journal.pone.0069910","article-title":"AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury","volume":"8","author":"Ji","year":"2013","journal-title":"PLoS One"},{"key":"2021113012300561500_B59","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/01.CIR.89.2.793","article-title":"Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes","volume":"89","author":"Sun","year":"1994","journal-title":"Circulation"},{"key":"2021113012300561500_B60","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1152\/jappl.1999.87.5.1990","article-title":"Chronic activation of 5\u2032-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle","volume":"87","author":"Holmes","year":"1999","journal-title":"J. Appl. Physiol."},{"key":"2021113012300561500_B61","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10557-016-6673-2","article-title":"Exogenous administration of recombinant MIF at physiological concentrations failed to attenuate infarct size in a langendorff perfused isolated mouse heart model","volume":"30","author":"Rossello","year":"2016","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/133\/5\/665\/845079\/cs-2018-1013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/133\/5\/665\/845079\/cs-2018-1013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:32:17Z","timestamp":1638275537000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/133\/5\/665\/219032\/Macrophage-migration-inhibitory-factor-plays-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,3,15]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20181013","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2019,3]]}}}